Development and Optimisation of a Stability-Indicating Analytical Method for Itraconazole in Drug Product by High-Performance Liquid Chromatography Using a QbD Approach

dc.contributor.authorFraschi Nieto, Alex
dc.contributor.authorMula Roldán, Xavier
dc.contributor.authorGavaldà Cánovas, Lluís
dc.contributor.authorMercadé Frutos, Débora
dc.contributor.authorGarcía Montoya, Encarna
dc.contributor.authorSuñé Pou, Marc
dc.contributor.authorPérez Lozano, Pilar
dc.date.accessioned2026-10-16T16:01:02Z
dc.date.available2026-10-16T16:01:02Z
dc.date.issued2026-07-10
dc.date.updated2026-10-16T16:01:07Z
dc.description.abstractBackground/Objectives: In this study, an analytical method by high-performance liquid chromatography (HPLC) that allows the determination of the content of the active ingredient itraconazole (ITZ), as well as the quantification of its degradation products and known impurities, is developed. Some of the existing methods, including the compendial ones, present long run times or different methods for the quantification of ITZ and the quantification of its impurities. Methods: In this article, an initial screening approach, starting on the described compendial methods, was conducted in order to establish the initial working conditions of the chromatographic method parameters. Once these parametric conditions were established, an optimisation was conducted utilising a statistical approach and a Design of Experiments (DoE), with the objective of attaining an optimised method that allows the quantification of ITZ and its related substances in one single injection. The data obtained during the DoE were processed using the Minitab® statistical programme. Once an optimised method was obtained, a short pre-validation assessment studying the selectivity, linearity and system suitability, among others, was carried out, confirming the suitability of the method for the intended use. Results: The resulting method employs an isocratic mobile phase of acetonitrile (ACN) and buffer (ammonium phosphate 10 mM at pH4.0), utilising a stationary phase of a Poroshell EC-C18 150 × 3.0 mm, 2.7 µm column. The retention time of itraconazole is 8.5–9.0 min, with a total chromatographic run time of 15 min. Conclusions: The developed method exhibits a shorter run time and greater Academic Editors: Michail Lykouras and Malvina Orkoula Received: 24 April 2026 Revised: 2 July 2026 Accepted: 3 July 2026 Published: 10 July 2026 Copyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. environmental sustainability compared to compendial methods, underscoring its improved analytical performance.
dc.format.extent25 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec771618
dc.identifier.issn1424-8247
dc.identifier.pmid42515747
dc.identifier.urihttps://hdl.handle.net/2445/232101
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ph19071066
dc.relation.ispartofPharmaceuticals, 2026, vol. 7, num.19, p. 1066
dc.relation.urihttps://doi.org/10.3390/ph19071066
dc.rightscc-by (c) Alex Fraschi-Nieto et al., 2026
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.classificationCromatografia de líquids d'alta resolució
dc.subject.classificationValidació (Medicaments)
dc.subject.classificationDisseny d'experiments
dc.subject.otherHigh performance liquid chromatography
dc.subject.otherValidation (Drug manufacture)
dc.subject.otherExperimental design
dc.titleDevelopment and Optimisation of a Stability-Indicating Analytical Method for Itraconazole in Drug Product by High-Performance Liquid Chromatography Using a QbD Approach
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
942547.pdf
Mida:
7.37 MB
Format:
Adobe Portable Document Format